ALOIN (b)

CAS No. 8015-61-0

ALOIN (b)( —— )

Catalog No. M20358 CAS No. 8015-61-0

ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 84 In Stock
10MG 116 In Stock
25MG 187 In Stock
50MG 259 In Stock
100MG 361 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALOIN (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
  • Description
    ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP|IL Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    8015-61-0
  • Formula Weight
    418.39
  • Molecular Formula
    C21H22O9?
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (239.01 mM)
  • SMILES
    [H][C@@]1([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Barrantes E Guinea M . Inhibition of collagenase and metalloproteinases by aloins and aloe gel[J]. Life Sciences 2003 72(7):0-850.
molnova catalog
related products
  • CTTHWGFTLC, CYCLIC

    This cyclic CTT Gelatinase Inhibitor peptide is an inhibitor for matrix metalloproteinases (MMP)-2 and MMP-9. It is also called type IV collagenase or gelatinase. Gelatinases are potential targets of therapeutic intervention in cancer, and inhibitors of these enzymes can prevent tumor progression.

  • T-26c

    T-26c is highly potent and selective matrix metalloproteinase-13 (MMP-13) inhibitor (IC50: 6.75 pM).

  • KP-457

    KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).